5,8,11,14-eicosatetraynoic acid has been researched along with Glioblastoma in 1 studies
5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, KM | 1 |
Petrik, D | 1 |
Mullane, K | 1 |
Harris, JE | 1 |
1 other study available for 5,8,11,14-eicosatetraynoic acid and Glioblastoma
Article | Year |
---|---|
Spontaneous chemiluminescence of ETYA (5,8,11,14-eicosatetraynoic acid) is inhibited by catalase or peroxidase.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Catalase; Free Radicals; Glioblastoma; Humans; Lu | 1994 |